Innovative solutions are needed to improve patient outcomes through faster diagnosis and earlier treatment​.

The problem

Healthcare systems globally are systematically challenged

Increasing lung cancer deaths

deaths globally

Single largest cause of cancer-related deaths globally

Rising outsourcing costs

Government spending on healthcare globally
is at an all time high

Rapid rises in outsourcing costs
(280% increase in volume in the last 6 years)

Record levels of patient backlog

backlog in the UK alone rising to 12m+

Radiologist shortage

Global shortage of trained radiologists

Key milestones

We are first to have regulatory approval in the UK and EU

Regulated by the Care Quality Commission

CQC Registered

First and only AI company to be registered by the CQC

FDA Cleared

FDA Cleared

FDA 510(k) clearance for triage of Pneumothorax

CE mark

CE Marking

First company with CE marking for diagnosis of CXRs

Commercial partnerships

Phase 4 AI Award Winner for national rollout

For our lung cancer detection platform and autonomous rule out on CXR being deployed across 10 UK NHS sites

Approved for NHS Share Business Framework

FDA 510(k) clearance for triage of Pneumothorax

US Distribution Partnership

Merative has over 23% of the PACS imaging systems market share in US.

India Distribution Partnership

Apollo Hospital Group is the largest hospital group in SE Asia with over 71 hospital locations across India.

Interested in talking to us about AI?

Get in touch to learn more about how red dot® can make a difference to your patients and your organisation.

Contact us

The team behind

See all

Regulated and recognised

We are the ONLY AI supplier that is regulated by the Care Quality Commission.